157 related articles for article (PubMed ID: 33899016)
1. Employing nanobodies for immune landscape profiling by PET imaging in mice.
Teunissen AJP; Abousaway OB; Munitz J; van Leent MMT; Toner YC; Priem B; Senders ML; Pérez-Medina C; Mulder WJM; Rashidian M
STAR Protoc; 2021 Jun; 2(2):100434. PubMed ID: 33899016
[TBL] [Abstract][Full Text] [Related]
2. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
3. (18)F-nanobody for PET imaging of HER2 overexpressing tumors.
Xavier C; Blykers A; Vaneycken I; D'Huyvetter M; Heemskerk J; Lahoutte T; Devoogdt N; Caveliers V
Nucl Med Biol; 2016 Apr; 43(4):247-52. PubMed ID: 27067045
[TBL] [Abstract][Full Text] [Related]
4. Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis.
Senders ML; Hernot S; Carlucci G; van de Voort JC; Fay F; Calcagno C; Tang J; Alaarg A; Zhao Y; Ishino S; Palmisano A; Boeykens G; Meerwaldt AE; Sanchez-Gaytan BL; Baxter S; Zendman L; Lobatto ME; Karakatsanis NA; Robson PM; Broisat A; Raes G; Lewis JS; Tsimikas S; Reiner T; Fayad ZA; Devoogdt N; Mulder WJM; Pérez-Medina C
JACC Cardiovasc Imaging; 2019 Oct; 12(10):2015-2026. PubMed ID: 30343086
[TBL] [Abstract][Full Text] [Related]
5. Engineering nanobodies for next-generation molecular imaging.
Yang E; Liu Q; Huang G; Liu J; Wei W
Drug Discov Today; 2022 Jun; 27(6):1622-1638. PubMed ID: 35331925
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use.
Lecocq Q; Zeven K; De Vlaeminck Y; Martens S; Massa S; Goyvaerts C; Raes G; Keyaerts M; Breckpot K; Devoogdt N
Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31569553
[TBL] [Abstract][Full Text] [Related]
7. Nanobodies for Medical Imaging: About Ready for Prime Time?
Berland L; Kim L; Abousaway O; Mines A; Mishra S; Clark L; Hofman P; Rashidian M
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33925941
[TBL] [Abstract][Full Text] [Related]
8. Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling.
Pruszynski M; Koumarianou E; Vaidyanathan G; Revets H; Devoogdt N; Lahoutte T; Lyerly HK; Zalutsky MR
J Nucl Med; 2014 Apr; 55(4):650-6. PubMed ID: 24578241
[TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.
Evazalipour M; D'Huyvetter M; Tehrani BS; Abolhassani M; Omidfar K; Abdoli S; Arezumand R; Morovvati H; Lahoutte T; Muyldermans S; Devoogdt N
Contrast Media Mol Imaging; 2014; 9(3):211-20. PubMed ID: 24700748
[TBL] [Abstract][Full Text] [Related]
10. ImmunoPET: Concept, Design, and Applications.
Wei W; Rosenkrans ZT; Liu J; Huang G; Luo QY; Cai W
Chem Rev; 2020 Apr; 120(8):3787-3851. PubMed ID: 32202104
[TBL] [Abstract][Full Text] [Related]
11. A nanobody-based nuclear imaging tracer targeting dipeptidyl peptidase 6 to determine the mass of human beta cell grafts in mice.
Demine S; Garcia Ribeiro R; Thevenet J; Marselli L; Marchetti P; Pattou F; Kerr-Conte J; Devoogdt N; Eizirik DL
Diabetologia; 2020 Apr; 63(4):825-836. PubMed ID: 31873789
[TBL] [Abstract][Full Text] [Related]
12. Radiometal-labeled anti-VCAM-1 nanobodies as molecular tracers for atherosclerosis - impact of radiochemistry on pharmacokinetics.
Bala G; Crauwels M; Blykers A; Remory I; Marschall ALJ; Dübel S; Dumas L; Broisat A; Martin C; Ballet S; Cosyns B; Caveliers V; Devoogdt N; Xavier C; Hernot S
Biol Chem; 2019 Feb; 400(3):323-332. PubMed ID: 30240352
[TBL] [Abstract][Full Text] [Related]
13. Nanobody: the "magic bullet" for molecular imaging?
Chakravarty R; Goel S; Cai W
Theranostics; 2014; 4(4):386-98. PubMed ID: 24578722
[TBL] [Abstract][Full Text] [Related]
14. Immuno-imaging using nanobodies.
Vaneycken I; D'huyvetter M; Hernot S; De Vos J; Xavier C; Devoogdt N; Caveliers V; Lahoutte T
Curr Opin Biotechnol; 2011 Dec; 22(6):877-81. PubMed ID: 21726996
[TBL] [Abstract][Full Text] [Related]
15. Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities.
Massa S; Vikani N; Betti C; Ballet S; Vanderhaegen S; Steyaert J; Descamps B; Vanhove C; Bunschoten A; van Leeuwen FW; Hernot S; Caveliers V; Lahoutte T; Muyldermans S; Xavier C; Devoogdt N
Contrast Media Mol Imaging; 2016 Sep; 11(5):328-339. PubMed ID: 27147480
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V
J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015
[TBL] [Abstract][Full Text] [Related]
17. Nanobodies as molecular imaging probes.
Barakat S; Berksöz M; Zahedimaram P; Piepoli S; Erman B
Free Radic Biol Med; 2022 Mar; 182():260-275. PubMed ID: 35240292
[TBL] [Abstract][Full Text] [Related]
18. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
[TBL] [Abstract][Full Text] [Related]
19. Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved in vivo detection.
Bannas P; Lenz A; Kunick V; Well L; Fumey W; Rissiek B; Haag F; Schmid J; Schütze K; Eichhoff A; Trepel M; Adam G; Ittrich H; Koch-Nolte F
Contrast Media Mol Imaging; 2015; 10(5):367-78. PubMed ID: 25925493
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis.
Zheng F; Put S; Bouwens L; Lahoutte T; Matthys P; Muyldermans S; De Baetselier P; Devoogdt N; Raes G; Schoonooghe S
J Nucl Med; 2014 May; 55(5):824-9. PubMed ID: 24686780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
